Company: JUNS
Filing Date: 2025-07-10
Form Type: 8-K
Source: 0001641172-25-018619
Chunk: 0

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-07-10
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events

As
previously reported to the Securities Exchange Commission on a Form 8-K filed on March 25, 2025, Jupiter Neurosciences, Inc. (the “ Company”)
received a letter (the “ Notice”) on March 21, 2025, from the Nasdaq Stock Market LLC (the “ NASDAQ”) notifying
the Company that it was not in compliance with the minimum bid price requirement as set forth under NASDAQ Listing Rule 5550(a)(2) for
continued listing of its Common Stock on the NASDAQ.

Listing
Rule 5550(a)(2) requires the registrant to maintain a minimum bid price of $1.00 USD per share for its securities listed on the NASDAQ,
and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for
a period of 30 consecutive business days. However, under NASDAQ Listing Rule 5810(c)(3)(A), the Company had 180 calendar days, or until
September 17, 2025, to regain compliance with NASDAQ Listing Rule 5550(a)(2) by maintaining a minimum bid price for its Common Stock
of at least $1.00 USD for a minimum period of 10 consecutive days.

The
Company is pleased to announced that on July 9, 2025, it received a written notice from the NASDAQ stating that the Company has since
regained compliance with Listing Rule 5550(a)(2) because the closing bid price of the Company’s Common Stock has been $1.00 USD
per share or greater for a period of thirteen (13) days (June 18, 2025 to July 8, 2025). The Company issued a press release on July 10,
2025, announcing that it has regained compliance with Listing Rule 5550(a)(2), a copy of which is attached as Exhibit 99.1 to
this Current Report on Form 8-K and incorporated by reference herein.

Item
9.01 Financial Statements and Exhibits.